Daiwa Securities Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3K | Hold |
314
| – | – | ﹤0.01% | 1198 |
|
|
2025
Q1 | $4K | Hold |
314
| – | – | ﹤0.01% | 1154 |
|
|
2024
Q4 | $4K | Hold |
314
| – | – | ﹤0.01% | 1178 |
|
|
2024
Q3 | $6K | Hold |
314
| – | – | ﹤0.01% | 1162 |
|
|
2024
Q2 | $6K | Hold |
314
| – | – | ﹤0.01% | 1185 |
|
|
2024
Q1 | $7K | Buy |
314
+72
| +30% | +$1.61K | ﹤0.01% | 1181 |
|
|
2023
Q4 | $5K | Hold |
242
| – | – | ﹤0.01% | 1199 |
|
|
2023
Q3 | $4K | Hold |
242
| – | – | ﹤0.01% | 1174 |
|
|
2023
Q2 | $5K | Hold |
242
| – | – | ﹤0.01% | 1179 |
|
|
2023
Q1 | $5K | Hold |
242
| – | – | ﹤0.01% | 1150 |
|
|
2022
Q4 | $6K | Buy |
242
+75
| +45% | +$1.86K | ﹤0.01% | 1139 |
|
|
2022
Q3 | $4K | Hold |
167
| – | – | ﹤0.01% | 1175 |
|
|
2022
Q2 | $3K | Hold |
167
| – | – | ﹤0.01% | 1200 |
|
|
2022
Q1 | $3K | Hold |
167
| – | – | ﹤0.01% | 1223 |
|
|
2021
Q4 | $4K | Hold |
167
| – | – | ﹤0.01% | 1222 |
|
|
2021
Q3 | $3K | Buy |
167
+74
| +80% | +$1.33K | ﹤0.01% | 1222 |
|
|
2021
Q2 | $2K | Hold |
93
| – | – | ﹤0.01% | 1151 |
|
|
2021
Q1 | $2K | Buy |
93
+16
| +21% | +$344 | ﹤0.01% | 1160 |
|
|
2020
Q4 | $2K | Buy |
+77
| New | +$2K | ﹤0.01% | 1135 |
|
|
2018
Q4 | – | Sell |
-135
| Closed | -$1K | – | 1160 |
|
|
2018
Q3 | $1K | Hold |
135
| – | – | ﹤0.01% | 1131 |
|
|
2018
Q2 | $1K | Hold |
135
| – | – | ﹤0.01% | 1154 |
|
|
2018
Q1 | $2K | Buy |
+135
| New | +$2K | ﹤0.01% | 1121 |
|